Use of transcriptomic signatures of <i>RAD51</i> and <i>GATA6</i> to predict real-world overall survival with platinum therapy in <i>BRCA/PALB2</i> wild-type metastatic pancreatic cancer.

Binbin Zheng-Lin, Tanios S. Bekaii-Saab, Cody Eslinger et al.|Journal of Clinical Oncology|2026

Cited by 0